Search tickers (stock/ETF/mutual fund)...
  • Screener
  • Watchlist
  • Charts
  • Gurus
  • Copilot
    Filings Search  
    Plans   
    Login   
    Register   
    Backtest Portfolio
    Portfolio Optimization
    Asset Correlations
    Efficient Frontier

    ADPT Gross Margin

    As of 2025-07-13, the Gross Margin of Adaptive Biotechnologies Corp (ADPT) is 59.7%.

    Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.

    ADPT Gross Margin - Historical Value
    DateValue
    2024-12-31 59.7%
    2023-12-31 55.6%
    2022-12-31 68.8%
    2021-12-31 68%
    2020-12-31 77.1%
    2019-12-31 73.8%
    2018-12-31 64.6%
    2017-12-31 59.1%
    -
    -
    ADPT Gross Margin - Peers Comparison
    TickerNameValue
    ABCLAbcellera Biologics Inc7775.2%
    ARCH.VArch Biopartners Inc20.2%
    BASIInotiv Inc3015.9%
    BLIBerkeley Lights Inc68.4%
    CDXCChromadex Corp61.8%
    CDXSCodexis Inc72.6%
    CGENCompugen Ltd71.5%
    CRLCharles River Laboratories International Inc34.8%
    CSBRChampions Oncology Inc41.4%
    EVIOEVIO Inc16.5%
    EVT.DEEvotec SE14.4%
    ICLRICON PLC29.5%
    IOT.VInnovotech Inc50.6%
    IQVIQVIA Holdings Inc34.9%
    LAXAFLaxai Pharma Ltd35%
    MEDPMedpace Holdings Inc31.1%
    MTSTMetaStat Inc-
    NEONeogenomics Inc43.9%
    NSTGNanoString Technologies Inc48.6%
    PACBPacific Biosciences of California Inc24.9%
    PBIOPressure Biosciences Inc40.4%
    PBSVPharma-Bio Serv Inc26.5%
    PRAHPRA Health Sciences Inc27.3%
    PSNLPersonalis Inc31.7%
    QMDTQuick-Med Technologies Inc97.3%
    RGDXQResponse Genetics Inc40.1%
    RP.VReplicel Life Sciences Inc100%
    SYNHSyneos Health Inc23.3%
    Tickers added to watchlist